PhilArchive
open access
N, N-DIMETHYLTRYPTAMINE AND BIOLOGICAL REDUCTIVE ACCOUNTS FOR RELIGIOUS AND SPIRITUAL EXPERIENCES
There is unquestionably a plethora of details and mysteries regarding the mind and the body. However, with the advent of psychopharmacology (the study of how psychedelics inform or alter brain states) there are more issues at hand. Do psychedelics allow us to access deeper areas of our consciousness? Are we having a spiritual experience under the influence of psychedelics? Dr. Rick Strassman does not want to continue asking these rather conspiratorial-like questions. Instead, Dr. Strassman believes that there is one special, endogenous psychedelic, synthesized within the human physiological framework: N, N-Dymthethyltryptamine. Dr. Strassman concludes that this chemical is produced within and around the pineal gland, and is often the catalyst for spiritual and religious experiences. I will explore this topic further under the framework of discovering whether a naturalistic type explanation of spiritual experiences accounts for all types of spiritual experiences and whether one may be rational or justified in believing in God if a naturalist could explain spiritual experiences.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.#1299
- Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies#1092527
- Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.#297141
- Personalised Perception: The Effect of Personality on the Sensory Effects of Psychedelics.#275639
- Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.#1107310
Record · ID 769029
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive